Dataset on safety and protective efficacy studies of COVID-19 vaccine candidates based on structurally modified plant virus in female hamsters
Open Access
- 19 April 2023
- journal article
- research article
- Published by Elsevier in Data in Brief
- Vol. 48, 109158
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Dataset on safety and protective efficacy studies of COVID-19 vaccine candidates based on structurally modified plant virus in female hamstersData in Brief, 2023
- Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an AdjuvantFrontiers in Microbiology, 2022
- Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster ModelmBio, 2021
- Sex differences in immune responses that underlie COVID-19 disease outcomesNature, 2020
- Plant virus particles with various shapes as potential adjuvantsScientific Reports, 2020
- Considering how biological sex impacts immune responses and COVID-19 outcomesNature Reviews Immunology, 2020
- Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infectionEmerging Microbes & Infections, 2020
- Obtaining and characterization of spherical particles—new biogenic platformsMoscow University Biological Sciences Bulletin, 2015